SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 67.80
-1.00 (-1.45%)
Oct 2, 2026, 5:30 PM CET
SKAN Group AG Market Cap
SKAN Group AG has a market cap or net worth of 1.52 billion as of October 2, 2026. Its market cap has increased by 25.05% in one year.
Market Cap
1.52B
Enterprise Value
1.58B
Revenue
363.25M
Ranking
n/a
PE Ratio
50.84
Stock Price
67.80
ChartMarket Cap Chart
Since April 10, 2007, SKAN Group AG's market cap has increased from 47.48M to 1.52B, an increase of 3,109.29%. That is a compound annual growth rate of 19.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.52B | 28.37% |
| Dec 30, 2025 | 1.19B | -30.71% |
| Dec 30, 2024 | 1.71B | -5.69% |
| Dec 29, 2023 | 1.82B | 28.25% |
| Dec 30, 2022 | 1.42B | -28.89% |
| Dec 30, 2021 | 1.99B | 1,168.29% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 279.40B |
| Novartis AG | 228.01B |
| Lonza Group AG | 40.17B |
| Galderma Group AG | 38.67B |
| Tecan Group AG | 2.89B |
| Medacta Group | 2.28B |
| PolyPeptide Group AG | 1.46B |
| Aevis Victoria | 1.34B |